Maintaining a good glycemic control is crucial in the management of diabetes mellitus (DM) as it is associated with the reduction in both macro and microvascular complications of the disease. Self-monitoring of blood glucose (SMBG), which provides the day-to-day blood glucose levels, is a simple and practical tool for maintaining a good glycemic control. Although SMBG is widely practiced in other countries, its use in India is very limited. Even when used, it is not carried out is a structured manner. There seems to be a lack of education about the purpose of SMBG and the correct process and schedule to be followed. This highlights the unmet need for country-specific SMBG recommendations. In order to fulfil this need, a panel of expert endocrinologists/ diabetologists came together under the aegis of Research Society for the Study of Diabetes in India (RSSDI). They reviewed the current literature, combined the evidences with their clinical knowledge and expertise, and developed consensus recommendations for SMBG practice in India. This document provides a comprehensive review of the current literature on SMBG and presents the recommendations made by the expert panel.
Yesudian CA, Grepstad M, Visintin E, Ferrario A. The economic burden of diabetes in India: a review of the literature. Glob Health. 2014;10:80. CrossRef
Scambler S, Newton P, Asimakopoulou K. The context of empowerment and self-care within the field of diabetes. Health (London). 2014;18(6):545–60. CrossRef
International Diabetes Federation. IDF Diabetes Atlas 8 th Edition. Available at: http://www.diabetesatlas.org/. Accessed on 24 th November 2017.
Mohan V. Why are Indians more prone to diabetes? J Assoc Physicians India. 2004;52:468–74. PubMed
Bhansali A. Cost of diabetes care: prevent diabetes or face catastrophe. J Assoc Physicians India. 2013;61(2):95. PubMed
Kumpatla S, Kothandan H, Tharkar S, Viswanathan V. The costs of treating long-term diabetic complications in a developing country: a study from India. J Assoc Physicians India. 2013;61(2):102–9. PubMed
Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract. 1995;28(2):103–17. PubMedCrossRef
UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352(9131):854–65. CrossRef
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352(9131):837–53. CrossRef
Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: the DCCT/EDIC study 30-year follow-up. Diabetes Care. 2016;39(5):686–93. CrossRef
Vashist SK. Continuous glucose monitoring systems: a review. Diagnostics (Basel). 2013;3(4):385–412. CrossRef
Benjamin EM. Self-monitoring of blood glucose: the basics. Clin Diabetes. 2002;20:45–7. CrossRef
FDA. Blood glucose monitoring test systems for prescription point-of-care use. FDA Document issued on: October 11, 2016. Available at: https://www.fda.gov/downloads/medicaldevices/deviceregulationandguidance/guidanced ocuments/ucm380325.pdf. Accessed on: April 3 rd, 2018.
Polonsky WH, Fisher L, Schikman CH, Hinnen DA, Parkin CG, Jelsovsky Z, et al. Structured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, noninsulin-treated type 2 diabetes: results from the structured testing program study. Diabetes Care. 2011;34(2):262–7. PubMedPubMedCentralCrossRef
Parkin CG, Hinnen DA, Tetrick DL. Effective use of structured self-management of blood glucose in type 2 diabetes: lessons from the STeP study. Clin Diabetes. 2011;29(4):131–8. CrossRef
Czupryniak L, Barkai L, Bolgarska S, Bronisz A, Broz J, Cypryk K, et al. Self-monitoring of blood glucose in diabetes: from evidence to clinical reality in central and Eastern Europe—recommendations from the international central-eastern European expert group. Diabetes Technol Ther. 2014;16(7):460–75. PubMedPubMedCentralCrossRef
Silva DD, Bosco AA. An educational program for insulin self-adjustment associated with structured self-monitoring of blood glucose significantly improves glycemic control in patients with type 2 diabetes mellitus after 12 weeks: a randomized, controlled pilot study. Diabetol Metab Syndr. 2015;7:2. PubMedPubMedCentralCrossRef
American Diabetes Association. 13. Management of diabetes in pregnancy: standards of medical care in diabetes 2018. Diabetes Care. 2018;41(Suppl 1):S137–43. CrossRef
Kesavadev J, Shankar A, Pillai PB, Krishnan G, Jothydev S. Cost-effective use of telemedicine and self-monitoring of blood glucose via Diabetes Tele Management System (DTMS) to achieve target glycosylated hemoglobin values without serious symptomatic hypoglycemia in 1,000 subjects with type 2 diabetes mellitus—a retrospective study. Diabetes Technol Ther. 2012;14(9):772–6. PubMedCrossRef
ISO In vitro diagnostic test systems—Requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus. ISO 15197:2013. Available at: https://www.iso.org/standard/54976.html Accessed on: 9 th March 2018.
Agborsangaya CB, Robitaille C, Dunbar P, Langlois MF, Leiter LA, Dai S, et al. Self-monitoring of blood glucose in type 2 diabetes: results of the 2011 survey on living with chronic diseases in Canada. Health Rep. 2013;24(6):3–8. PubMed
Barnett AH, Krentz AJ, Strojek K, Sieradzki J, Azizi F, Embong M, et al. The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study). Diabetes Obes Metab. 2008;10(12):1239–47. PubMed
Diabetes Control and Complications Trial Research Group, Nathan DM, Genuth S, Lachin J, Cleary P, Crofford O, et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329(14):977–86. CrossRef
International Diabetes Federation Guideline Development Group. Global guideline for type 2 diabetes. Diabetes Res Clin Pract. 2014;104(1):1–52. CrossRef
Towfigh A, Romanova M, Weinreb JE, Munjas B, Suttorp MJ, Zhou A, et al. Self-monitoring of blood glucose levels in patients with type 2 diabetes mellitus not taking insulin: a meta-analysis. Am J Manag Care. 2008;14(7):468–75. PubMed
Malanda UL, Welschen LM, Riphagen II, Dekker JM, Nijpels G, Bot SD. Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin. Cochrane Database Syst Rev. 2012;1:CD005060. PubMed
Farmer AJ, Perera R, Ward A, Heneghan C, Oke J, Barnett AH, et al. Meta-analysis of individual patient data in randomised trials of self monitoring of blood glucose in people with non-insulin treated type 2 diabetes. BMJ. 2012;e486:344.
Parsons S, Luzio S, Owens DR. The SMBG study: structured self-monitoring of blood glucose in non-insulin treated type 2 diabetes. IDF congress 2017; 4–8 December Abu Dhabi; Abstract OP-0073.
Durán A, Martín P, Runkle I, Pérez N, Abad R, Fernández M, et al. Benefits of self-monitoring blood glucose in the management of new-onset type 2 diabetes mellitus: the St Carlos study, a prospective randomized clinic-based interventional study with parallel groups. J Diabetes. 2010;2(3):203–11. PubMedCrossRef
DiaTribe (2015, April 16). Google secures patent for glucose-sensing contact lens. Available at: Retrieved from https://diatribe.org/google-secures-patent-glucose-sensing-contact-lens. Accessed on: 8 th March 2018.
HAPO Study Cooperative Research Group, Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358(19):1991–2002. CrossRef
IDF Clinical Guidelines Task Force. Global guideline on pregnancy and diabetes. Brussels: International Diabetes Federation; 2009.
NHM Diagnosis & management of gestational diabetes mellitus, technical and operational guidelines, by Maternal Health Division Ministry of Health and Family Welfare, Government of India, February 2018. Available at: http://nhm.gov.in/New_Updates_2018/NHM_Components/RMNCH_MH_Guidelines/Ge stational-Diabetes-Mellitus.pdf. Accessed on: 1 st May 2018.
International Diabetes Federation. IDF guideline on self-monitoring of blood glucose in non-insulin treated type 2 diabetes. Brussels, 2009. Available at: https://www.idf.org/e-library/guidelines/85-self-monitoring-of-blood-glucose-in-non-insulin-treated-type-2-diabetes.html Accessed on 29 th December 2017.
Unnikrishnan R, Mohan V. Protocols of SMBG in various insulin regimens—a practical guide for titration and control. Frontiers in Medicine. 2009;23:39–41.
SMBG International Working Group. Self-monitoring of blood glucose in type 2 diabetes: an inter-country comparison. Diabetes Res Clin Pract. 2008;82(3):e15–8. CrossRef
Mastura I, Mimi O, Piterman L, Teng CL, Wijesinha S. Self-monitoring of blood glucose among diabetes patients attending government health clinics. Med J Malaysia. 2007;62(2):147–51. PubMed
Mohan V, Deepa R, Shefali AK, Poongothai S, Monica M, Karkuzhali K. Evaluation of one touch HORIZON—a highly affordable glucose monitor. J Assoc Physicians India. 2004;52:779–82. PubMed
- RSSDI consensus on self-monitoring of blood glucose in types 1 and 2 diabetes mellitus in India
P. V. Rao
B. M. Makkar
A. K. Das
A. K. Singh
C. H. Vasanth Kumar
C. R. Anand Moses
K. R. Narasimha Setty
S. V. Madhu
Shashank R Joshi
S. R. Aravind
- Springer India
International Journal of Diabetes in Developing Countries
Incorporating Diabetes Bulletin
Print ISSN: 0973-3930
Elektronische ISSN: 1998-3832